| No. of patients (70) | % |
---|---|---|
Age, median (range, year) | 70 (44–85) |  |
Gender | ||
Male | 48 | 69 |
Female | 22 | 31 |
Histology | ||
Adenocarcinoma | 54 | 77 |
Squamous | 15 | 22 |
NOS | 1 | 1 |
Stage | ||
IIIB | 3 | 4 |
IV | 67 | 96 |
ECOG PS | ||
0 | 25 | 36 |
1 | 39 | 56 |
2 | 6 | 8 |
Smoking habits | ||
Never smoker | 9 | 13 |
Former smoker | 35 | 50 |
Smoker | 26 | 37 |
Prior lines of therapy | Median 2 (range 1–6) |  |
1 | 28 | 40 |
2 | 20 | 29 |
3 | 13 | 19 |
≥ 4 | 9 | 12 |
CEA (ng/ml) baseline | ||
Median (range) | 6.6 (0.80–2615) |  |
Normal (< 5) | 30 | 43 |
Elevated (≥ 5) | 40 | 57 |
CYFRA 21-1 (ng/ml) baseline | ||
Median (range) | 5.0 (0.2–126.4) |  |
Normal (< 3.3) | 25 | 36 |
Elevated (≥ 3.3) | 45 | 64 |
NSE (ng/ml) baseline | ||
Median (range) | 7.5 (3.1–46.8) |  |
Normal (< 3.3) | 56 | 80 |
Elevated (≥ 3.3) | 14 | 20 |